Pharmacist Led Intervention to Improve Medication Use in Older In-patients Living With Frailty: the Drug Burden Index
1 other identifier
interventional
200
1 country
1
Brief Summary
Older people in Canada commonly take multiple medicines for their health conditions. Certain medicines, especially when taken together can lead to serious harms, such as falls. As people age and their health changes, medicines that were once helpful may become harmful. Healthcare professionals recognise that better tools and procedures are needed to make sure that people are taking the right medicines at the right time. A tool has been recently created, called the Drug Burden Index (DBI) Calculator©, to be used by hospital pharmacists. It helps them identify which medicines (and combinations of medicines) are harmful to older people. This tool also produces reports for the doctor and for the older person and their family. In this study, hospital pharmacists will use the DBI calculator© during their normal activities. The investigators will measure what effect this has on the medicines used and health outcomes in older adults. The investigators are also interested in what influences use and impact of the calculator. For example, there may be differences in use in older males compared to females or in the benefits seen in people living with frailty compared to those who are not frail. Use of the DBI calculator© may lead to improvements in how medicines are managed in hospital. This would mean less drug costs and drug side effects. Overall, the project may lead to improving the quality of life for older Canadians. Hypothesis: Implementation of a ward-based, pharmacist-led intervention utilizing the DBI Calculator© will lead to optimization of medications, reduced DBI and improved health outcomes in frail and non-frail older adults.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 2, 2018
CompletedFirst Posted
Study publicly available on registry
October 9, 2018
CompletedStudy Start
First participant enrolled
February 6, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2024
CompletedFebruary 7, 2024
February 1, 2024
5.5 years
October 2, 2018
February 6, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Number of participants with changed or unchanged DBI score at discharge compared to admission
• Proportion of inpatients in whom DBI is decreased, unchanged or increased at discharge, compared to on admission to hospital
Up to 12 weeks
Secondary Outcomes (5)
Number of participants with changed (or unchanged) DBI score
90 days
Total number of medications
90 days
Clinical outcomes during hospitalization
Up to 12 weeks
Clinical outcomes after hospitalization
90 days
Pharmacist time
Up to 12 weeks
Study Arms (2)
Retrospective Chart Review
NO INTERVENTIONSpecifically, it consists of: * A retrospective study (NB: ethics for this part of the overall study has been sought separately and already approved, file number 1023666). * A before/after intervention * A multiple case study (a sub-study of the before/after intervention)
Intervention
ACTIVE COMPARATOR* A before/after intervention * A multiple case study (a sub-study of the before/after intervention)
Interventions
Pharmacist-led medication optimization intervention using an electronic tool (DBI Calculator©). The DBI Calculator is an electronic tool which calculates a score from the medication reconciliation list (medications taken prior to admission). It also creates a 'DBI report' which includes their full medication list, their DBI score, an explanation of the risks associated with their DBI score and highlighted medications which are contributing to their DBI score (that is, high risk medications which may be suitable for deprescribing).
Eligibility Criteria
You may qualify if:
- Age ≥70 years old
- DBI score \>0 (taking ≥1 regular medication with a sedative or anticholinergic effect prior to admission)
- Informed consent able to be obtained from patient or substitute decision maker as per hospital policy
- Able to communicate in English (as DBI report only available in English)
You may not qualify if:
- Expected discharge within 24 hours of recruitment or 48 hours of admission
- Terminal phase of illness (expected to die during current admission) OR noted to be 'palliative care'
- Usual residence outside Nova Scotia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Emilylead
- Canadian Frailty Networkcollaborator
Study Sites (1)
Nova Scotia Health Authority QE2/DGH
Halifax, Nova Scotia, B3H 2E1, Canada
Related Publications (2)
Dearing ME, Bowles S, Isenor J, Kits O, Kouladjian O'Donnell L, Neville H, Hilmer S, Toombs K, Sirois C, Hajizadeh M, Negus A, Rockwood K, Reeve E. Pharmacist-led intervention to improve medication use in older inpatients using the Drug Burden Index: a study protocol for a before/after intervention with a retrospective control group and multiple case analysis. BMJ Open. 2020 Feb 20;10(2):e035656. doi: 10.1136/bmjopen-2019-035656.
PMID: 32086361BACKGROUNDDearing M, Bowles SK, Isenor JE, Weir KR, O'Donnell LK, Kits O, Hilmer SN, Neville H, Rockwood K, Sirois C, Hajizadeh M, Toombs K, Susin A, Reeve E. Effectiveness of a pharmacist-led deprescribing intervention in older inpatients: an implementation study with retrospective control group. Eur Geriatr Med. 2026 Jan 29. doi: 10.1007/s41999-025-01371-0. Online ahead of print.
PMID: 41609981DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Affiliate Scientist
Study Record Dates
First Submitted
October 2, 2018
First Posted
October 9, 2018
Study Start
February 6, 2019
Primary Completion
August 1, 2024
Study Completion
August 1, 2024
Last Updated
February 7, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Immediately after publication of final manuscript and up to 5 years after.
- Access Criteria
- Requests to access the data can be made by email to the corresponding author.
Individual participant data that underlie the results reported in manuscripts, after deidentification (text, tables, figures and appendices) may be made available where proposed use of the data has been approved by an independent ethics review committee.